Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Verteporfin for Scar Prevention in Patients After Surgical Wounds
DenmarkDB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
FranceRituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease
FranceLebrikizumab in Adults with Moderate to Severe Localized Scleroderma
GermanyREGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma
FranceA study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma
SpainSafety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)
ItalyComparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis
FinlandA study to evaluate the safety and effectiveness of dalbavancin in patients with erysipelas or limited cellulitis being treated at home.
AustriaA study to evaluate the effectiveness of oxygen and narrow-band UVB phototherapy for treating patients with diffuse vitiligo
FranceA study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis
CzechiaA study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma
The NetherlandsThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
